JPRN-UMIN000017619招募中未知
Effects of Vildagliptin addition versus standard therapy on glycemic excursion in type2 diabetic patients after coronary intervention therapy: a 8-months, randomized, open-label, parallel-group comparison. - Effects of Vildagliptin addition versus standard therapy on glycemic excursion in type2 diabetic patients after coronary intervention therapy: a 8-months, randomized, open-label, parallel-group comparison.
Teikyo University School of Medicine0 个研究点目标入组 60 人开始时间: 2015年5月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Exclusion criteria will comply with local label 2) Coronary bypass graft operation 3) Severe valvular heart disease 4) Severe arrhythmia (Extrasystole > 10% of total beats, atrial fibrillation, atrial flutter, pacemaker implantation, high grade heart block) 5) Congestive heart failure (NYHA III, IV) 6) Malignant neoplasms 7) Use of gluco-corticosteroids, immuno-suppressant 8) Serum Cr > 2.5 mg/dl 9) Cerebrovascular infarction or hemorrhage 10) Aneurysms in great artery 11) Liver cirrhosis 12) Recent (within 4 weeks) usage of incretin related drugs 13) Blood glucose > 400mg/dl or insulin usage 14) Recent change in diabetic treatment in one month 15) Use of Insulin, GLP-1 analogue, and OHAs excluding SU and metformin
研究者
相似试验
已完成
不适用
To compare the effect of pioglitazone vs vildagliptin in type 2 diabetes mellitus patients not responding to combination of metformin and sulfonylureas.CTRI/2013/04/003582investigator initiated trial50
进行中（未招募）
1 期
Study of the Effect of Vildagliptin versus Dapagliflozin on Glucagon Response to Mixed Meal in Metformin-treated Subjects with Type 2 DiabetesType 2 Diabetes MellitusEUCTR2015-001334-21-SEund University
未知
3 期
Efficacy and safety of vildagliptin as add-on therapy to metformin in patients with type 2 diabetesType 2 diabetes mellitusJPRN-jRCT2080221679ovartis Pharma K.K.136
进行中（未招募）
不适用
Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes - Effect of adding vildagliptin to insulin treatmentpatients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin (2 x 850)MedDRA version: 9.1Level: LLTClassification code 10012594Term: DiabetesEUCTR2009-010967-18-NLniversity Medical Centre Utrecht40
已完成
3 期
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetesDiabetesNL-OMON37974Academisch Medisch Centrum40